The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
On that basis we just need someone to buy another 24000 shares and we all double our money! ;-)
Here's the link for anyone else interested...
https://event.webinarjam.com/register/945/5vv20b3vp
Well there's another 67,198 shares in my account this morning, although as usual, not showing in the lists of trades yet...
Looking forward to the next RNS anytime soon!
Took 11 days but we got there in the end... £2+
With buys like this it should finish blue...
22-Feb-21 09:01:34 31.00 450,000 Buy* 30.00 31.00 139.50k O
Would have expected a much bigger rise in the SP this morning after this news but I guess some people aren't connecting the dots...
This is a company that have already announced that last year revenues are over £50m (up from £21m the previous year), EBITDA is £14m (an almost fivefold increase), 2021 trading has started strongly and they have a debt free balance sheet yet their Market Cap is only circa 10 times EBITDA.
For a company in this space and one that is growing as fast as this their MC should be getting close to double that as even without COVID they have a prosperous future.
I'm sure as they win more contracts people will wake up to this being a great investment opportunity.
WuhanMarket
Invesco have been selling for ages and despite that the SP is up over 20% this year so why would you advise people to wait until they have finished selling their remaining shares? All shares have dips from time to time!
That's a question that only Invesco can answer Investor3590...
Yep, looking good...
18-Feb-21 09:34:07 30.80 1,596,916 Buy* 30.50 31.00 491.85k O
JohnHenry
15 times profit for PE would be for a business growing reasonably well but not for one growing at this pace. PE would use a multiple of at least double that for something growing this fast.
I sold my business to PE at 24 times and we were 'only' growing at 43% year on year. My understanding is CF's $1billion valuation (that's $s rather than £s) doesn't include the spin offs.
The 47991 buy has just been shown as a sell and the 89605 buy is yet to appear... And before anyone gives me a lecture that sometimes buys and sells get mixed up, I know. Just moaning that it's difficult to see what's going on when buys show as sells or don't appear at all...
Just bought another 47991 and 89605 in two separate tranches at 30p but not showing up yet...?
Finding it difficult to understand why the last 20+ transactions have pretty much all been sells when you'd need to be a few sandwiches short of a picnic to sell this now!
Get your FACTS right Horace.! Investec aren’t dumping ANY shares as they don’t hold any! Invesco do but not Investec!
Filtered...!
This should be transformational...
"...HeiQ Viroblock has the potential to become a household detergent product as a post-treatment for laundered goods..."
If you could wash your clothes in something that protected you against any virus I think most households would buy a detergent that does that. Can't believe this isn't already above £2 this morning.
And Part 2
but the B2C aspect of this agreement means that we will enhance recognition of the HeiQ brand in line with our strategy to increase our B2B, B2C and B2B2C sales and brand profile. We have a very healthy innovation pipeline, both in respect to HeiQ Viroblock and our other core technologies, 200 of which are active on the market and 40 more in the pipeline. We look forward to providing additional updates in due course."
Girbau President Serge Joris said:
"I am thrilled with the partnership between HeiQ and Girbau, as it represents an important milestone in our journey to create textile treatment solutions that have a positive impact on people. Especially given the current circumstances, which have caused people to be anxious, businesses have a responsibility to offer solutions which protect their communities. This partnership is another positive leap in terms of differentiating Girbau's offering in the textile industry. The partnership demonstrates once again how two innovative companies can contribute to a better world by joining forces."
RNS Number : 6895O
HeiQ PLC
11 February 2021
11 February 2021
HeiQ Plc
("HeiQ" or "the Company")
HeiQ Viroblock Contract Win and Expansion into New Market
HeiQ (LSE:HEIQ), an established global brand in materials and textile innovation which operates in high-growth markets, is pleased to announce that it has signed a four year partnership with Girbau, a world leader in comprehensive professional laundry solutions for the industrial, commercial and vended sectors. The contract is valued at a minimum of US$1.5 million, with the potential to increase substantially.
Pursuant to this contract, Girbau will offer its customers HeiQ's Viroblock NPJ03 product as an antiviral and antimicrobial post-treatment for its industrial laundry services. Girbau has clients across the healthcare, hospitality and food manufacturing sectors, where hygiene and safety are paramount, and this contract provides significant additional revenue opportunities for HeiQ. HeiQ and Girbau also plan to offer solutions to public launderettes, bringing branded HeiQ Viroblock dispensers to consumers. While the HeiQ Viroblock technology platform consists of multiple different applications and is active in various sectors, this is the first time that HeiQ Viroblock has been utilised within the laundry sector. This means that HeiQ Viroblock has the potential to become a household detergent product as a post-treatment for laundered goods, opening up a large and growing new market to HeiQ. The laundry detergent market is estimated at US$132 billion per year and grows at 4.5% CAGR (statista.com).
Under this contract, HeiQ will initially focus on a B2B offering, with a particular focus on bringing enhanced antimicrobial and antiviral protection to garments and textiles used in the healthcare and hospitality sector. The detergent market is dominated by players like Ecolab, Unilever, Reckit Benkiser, Henkel and Procter & Gamble, which typically do not focus on functional detergents conferring long lasting properties to textiles. Therefore, HeiQ is the first textile technology company to convert an industrial antiviral treatment into a functional detergent.
HeiQ co-founder and CEO Carlo Centonze said:
"This deal demonstrates the breadth of new market opportunities available to HeiQ Viroblock and means that a significant number of people around the world will be protected by our Swiss Technology Award-winning antimicrobial technology. The four-year nature of this agreement demonstrates the industry belief that antimicrobial functionality is here to stay. We are delighted to open up this significant new market which we believe has the potential to deliver substantial value to shareholders. At a minimum, this contract will deliver US$1.5m of additional revenue for the business over four years but has the potential to go much further. We will first focus on servicing B2B customers,
Seems to be heading north at a nice steady pace this week and about time...
15:56 Bid was 29p
15:57 RNS telling us what we already know (that Invesco are exiting)
130k shares sold
230k shares bought
And the Bid drops to 28p... Someone is having a laugh at our expense!
It seems that every time we look like breaking 30p somebody sells... 9 x sells of exactly 50k shares 2 x 300k and 3 x 100k+ sells over the last 24 hours of trading... Is this Invesco continuing their exit I wonder...? Can't go on forever!